Nema Health Raises $14.5 Million Series A to Expand Virtual PTSD Treatment Model and Promote Long-Term Healing

Led by Deerfield Management and CVS Health Ventures, funding round to facilitate growth in new states, including California, Florida, Pennsylvania

NEW HAVEN, Conn., Jan. 8, 2025 /PRNewswire/ -- Nema Health, the leading solution for virtual trauma and PTSD care, today announced its $14.5 million Series A funding round led by Deerfield Management, an investment firm dedicated to advancing healthcare through information, investment, and philanthropy, alongside new participant CVS Health Ventures, CVS Health's venture capital arm. Nema's existing investors, Optum Ventures, .406 Ventures, and GreyMatter, also participated, rounding out a team of dedicated investors and board members to propel forward the company's mission to enable long-lasting healing & peace for all trauma survivors.

"80% of people will endure trauma in their lifetimes – from domestic and sexual violence to child abuse, gun violence, car accidents, war, climate disasters and pregnancy loss – and 20% will go on to develop PTSD," said Dr. Sofia Noori, Co-founder and CEO of Nema Health. "We've built Nema to bring evidence-based treatment and rapid relief to trauma survivors – helping them regain strength, find long-term healing, and build big, joyful lives."

Nema, which is physician- and survivor-led, has designed a virtual treatment program based in Cognitive Processing Therapy (CPT), the most effective care for PTSD. Nema's therapy model is peer-led, meaning that other trauma survivors are there with patients from their very first interaction all the way through to their recovery. Nema's clinical approach teaches individuals how to challenge and modify their belief systems related to how they see their trauma, themselves, and the world. The most powerful part of Nema's treatment is its ability to provide rapid relief: after completing just 4-6 weeks of Nema's intensive PTSD care, 91% of patients experience clinical improvement and 82% no longer meet criteria for a diagnosis of PTSD. Nema's clinical model helps patients learn how to rebuild their relationships, intimacy, and trust in themselves and others — the cornerstones of healing after trauma.

"While innovation from the health tech industry has flooded into other areas of behavioral health, PTSD has remained largely untouched," said Dr. Julian Harris, Operating Partner at Deerfield. "But Dr. Noori and the team at Nema have taught us that PTSD does not have to be a debilitating, lifelong illness – it can be treated effectively, enabling patients to begin a new chapter in their lives. Nema's accessible virtual treatment model and team of clinicians makes healing possible for the more than 13 million Americans struggling with PTSD today."

As part of its continued expansion, Nema has launched its model in eight states since its 2023 launch – New Jersey, New York, Connecticut, California, Massachusetts, Pennsylvania, Florida, and Illinois – with plans to expand to many more states this year. Nema is in-network with multiple national and regional health plans and is devoted to partnering rapidly with more health plans to improve affordability for its treatment for trauma survivors of all walks of life. The Series A investment will allow Nema to continue to expand its treatment across markets, broaden insurance coverage, and continue deepening its care offerings to solidify its position as the country's leading trauma care company.

About Nema Health
Survivor and clinician-led, Nema Health delivers evidence-based, virtual PTSD treatment to help trauma survivors find lasting peace and healing. Nema is in-network with several major commercial insurance plans and currently offers treatment in New Jersey, New York, Connecticut, California, Massachusetts, Pennsylvania, Florida, and Illinois.

SOURCE Nema Health